OET Reading Part C
↓ Find more practice questions here.
Virtual reality in the management of pain
When headsets promising immersive pain relief first appeared at medical technology exhibitions, the response from pain specialists was largely sceptical. Most had seen a succession of over-promoted devices arrive and disappear and expected virtual reality (VR) to follow the same path. One senior anaesthetist dismissed the equipment as an expensive toy, observing that a paperback novel occupied a patient’s mind at a fraction of the cost. Two decades later, that verdict appears premature. VR is now supported by a larger body of evidence than several long-established analgesic techniques, and some of its early critics sit on the advisory boards of the companies that manufacture the headsets.
The earliest rigorous studies took place in burns units, arguably the most demanding setting available. Wound cleaning and dressing changes for severe burns are so painful that even high doses of opioid analgesics frequently fail to control the experience. A research group in Seattle developed SnowWorld, a virtual glacial canyon through which patients drifted while throwing snowballs at penguins, and recorded what happened when dressings were changed during play. Patients reported reductions of between a third and a half in their worst pain, in addition to the relief provided by their usual medication, and spent considerably less time thinking about their wounds. Such findings, however, rested entirely on self-report, which is precisely what a sceptic would expect an absorbing game to alter. What persuaded many doubters was neuroimaging: scans taken during VR sessions showed markedly reduced activity in the regions of the brain that process incoming pain signals. The effect, in other words, was not merely imagined.
The conventional explanation is attention. Pain is not a fixed quantity transmitted unchanged from injury to brain; the experience is constructed centrally, and attention is one of the mechanisms that shape it. A brain occupied with dodging virtual snowballs has, quite literally, reduced capacity to process the signal arriving from a wound. On this account, VR is essentially distraction with superior graphics. Some researchers, however, regard this as incomplete. Professor Daniel Okafor, who studies pain perception at a Canadian university, argues that immersion achieves something entertainment does not. ‘When the brain accepts a virtual body as its own, its map of the real body, including the painful part, can begin to be redrawn,’ he suggests. ‘No film or novel achieves that.’
That possibility is most relevant to chronic pain. Acute procedural pain is a relatively straightforward target: the painful event is brief, and any intervention that carries the patient through it has served its purpose. Persistent pain is another matter because it frequently continues in the absence of ongoing tissue damage and becomes entangled with fear, low mood and avoidance of movement. Thirty minutes in a glacial canyon offers little to a person who lives with pain day and night. The newer VR programs therefore resemble therapy rather than games: graded virtual movement for patients afraid to bend their backs; illusions that appear to shrink a swollen, painful limb; and structured courses teaching the neuroscience of pain from inside a headset. Regulators in the United States have now authorised one such eight-week program as a prescription treatment for chronic lower back pain.
Not all of those involved in the research share this enthusiasm. Dr Elena Marsh, who leads a VR research group in Manchester, argues that the principal weakness of the field lies in the quality of its evidence rather than in the underlying concept. ‘Most trials are small, short, and conducted by people who, like me, would prefer the technology to succeed. Nor can patients be unaware of whether they entered a virtual world, so expectation colours almost every result we have,’ she says. Her concern is not that VR is ineffective but that the commercial market is advancing faster than the science, with hundreds of wellness applications now sold on the strength of a small number of rigorous studies. Before any firm conclusions are drawn, she would like to see a single large, independent trial lasting a full year.
A balanced assessment therefore lies somewhere between the early dismissals and the promises of the marketing brochures. For severe, short-lived pain during medical procedures, VR has established itself as an adjunct to standard analgesia rather than a substitute for it, and any technique that reduces reliance on opioid medication merits serious attention. For chronic pain, it represents a promising form of therapy that still awaits the large, independent trials required to justify the claims made on its behalf. The charge that it offers nothing more than entertainment, at least, is difficult to sustain: entertainment has never been shown to quieten the brain’s processing of pain.
The clinical significance of noise on hospital wards
When patients are asked what they recall of a hospital admission, alongside anxiety and physical discomfort, a remarkable number mention something altogether more mundane: they could not sleep for the noise. Bin lids crashing, monitors sounding, staff conversing at the desk, the trolley with the squeaking wheel that always seems to pass at four in the morning. For many years, such complaints were regarded as the unavoidable background of a busy institution: regrettable, perhaps, but hardly a clinical concern. That assumption is now being questioned, as evidence accumulates that sleep is not a luxury the sick can forgo but part of the process by which they recover.
The measurements are striking. The World Health Organization advises that background noise in patient areas should not exceed 35 decibels, roughly the hush of a quiet library, with lower levels still recommended at night. Surveys of functioning wards regularly record averages above 55 decibels, with peaks (a dropped bedpan, an alarm) exceeding 85, the level at which employees in industry would be issued with hearing protection. In acoustic terms, a patient attempting to sleep on such a ward is resting beside a busy main road that periodically erupts into a pneumatic drill. Nor is waking the only concern. Dr Ingrid Sørensen, a sleep physiologist at a university hospital in Copenhagen, points out that much of the damage is invisible. ‘Sounds too quiet to wake a patient still produce measurable arousals. The sleeper is drawn again and again out of the deeper stages into lighter ones, usually with no memory of it,’ she explains.
Why should clinicians care? Because the consequences extend well beyond next-day tiredness. Poor sleep in hospital has been associated with delirium – the sudden, temporary confusion that prolongs admissions and, in older patients, predicts poorer recovery long after discharge. Sleep deprivation also raises blood pressure and stress hormones, weakens resistance to infection and interferes with the regulation of blood sugar, a particular hazard for the many inpatients who have diabetes. The effect is circular: patients are admitted because they are unwell, the ward disturbs the sleep their recovery requires, and the deterioration that follows extends the very stay that is costing them their rest. The ward, in short, works against the treatment delivered on it.
Equipment is the obvious suspect, and monitoring devices certainly generate an extraordinary number of alarms; a nurse in intensive care may deal with several hundred in a single shift. Yet studies in which wards were recorded overnight point elsewhere. Professor Marcus Bell, a nursing researcher in Melbourne whose team conducted one such study, found that the loudest and most disruptive sounds were seldom mechanical. ‘The peaks that actually woke patients were people: conversation, laughter and handover at full volume, often within a few metres of patients assumed to be asleep,’ he reports. The finding is uncomfortable because it locates the source of the disturbance in the very people employed to provide care. It is also encouraging, because behaviour, unlike the design of a cardiac monitor, can be modified without additional funding or equipment.
Several responses have proved reassuringly simple. Some wards have introduced ‘quiet time’, a protected period in the afternoon and again at night during which lighting is lowered, non-urgent tasks are deferred and voices are kept down. Those adopting the approach report measurable falls in sound levels together with improvements in patients’ own ratings of their sleep. Others distribute earplugs and eye masks, an intervention so inexpensive that it scarcely registers on a budget, yet one shown in trials to reduce the incidence of delirium. A few have appointed a ‘noise champion’ on each shift, whose sole responsibility is to notice when the ward has grown loud and to say so, a role that sounds trivial until one remembers how quickly a busy team ceases to hear itself. Acoustic panels, quieter flooring and soft-closing bins blunt the sharpest peaks. None of this is glamorous, and none of it will generate headlines, which may be precisely why the problem was neglected for so long: there is little professional glory in asking colleagues to lower their voices.
Perhaps the deepest obstacle is attitudinal. A busy, noisy ward can feel, to the team working on it, like a hard-working one, and quiet can be mistaken for idleness. Alarms, however wearing, resemble vigilance, and there is an understandable reluctance to silence anything that might occasionally matter. Yet the evidence increasingly indicates that an institution serious about recovery must treat the sound surrounding its patients as it treats hygiene or the safe administration of medicines: as a factor that shapes how well people get better rather than an afterthought. The patient kept awake by the squeaking trolley is not merely irritated. That patient is, in a small but genuine way, being prevented from recovering.